REFERENCES
- Fenton SS, Schaubel DE, Desmeules M, . Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334–342.
- Serkes KD, Blagg CR, Nolph KD, Vonesh EF, Shapiro F. Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: A multicenter study. Perit Dial Int. 1990;10:15–19.
- Johnson DW, Dent H, Hawley CM, . Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol. 2009;4:1620–1628.
- Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010;21:499–506.
- Oreopoulos DG, Ossareh S, Thodis E. Peritoneal dialysis: Past, present, and future. Iran J Kidney Dis. 2008;2:171–182.
- USRDS. The United States Renal Data System. Am J Kidney Dis. 2003;42:1–230.
- Han SH, Lee SC, Ahn SV, . Improving outcome of CAPD: Twenty-five years’ experience in a single Korean center. Perit Dial Int. 2007;27:432–440.
- Phelan PJ, O’Kelly P, Walshe JJ, Conlon PJ. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients. Ren Fail. 2008;30:423–429.
- Trivedi H, Tan SH, Prowant B, . Predictors of death in patients on peritoneal dialysis: The Missouri Peritoneal Dialysis Study. Am J Nephrol. 2005;25:466–473.
- Prasad N, Gupta A, Sinha A, . A comparison of outcomes between diabetic and nondiabetic CAPD patients in India. Perit Dial Int. 2008;28:468–476.
- Liao CT, Chen YM, Shiao CC, . Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant. 2009;24:2909–2914.
- Mehrotra R, Duong U, Jiwakanon S, . Serum albumin as a predictor of mortality in peritoneal dialysis: Comparisons with hemodialysis. Am J Kidney Dis. 2011;58:418–428.
- Jones CH, Newstead CG, Wills EJ, Davison AM. Serum albumin and survival in CAPD patients: The implications of concentration trends over time. Nephrol Dial Transplant. 1997;12:554–558.
- Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8:1094–1098.
- Sipahioglu MH, Aybal A, Unal A, Tokgoz B, Oymak O, Utas C. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years’ experience in a single center. Perit Dial Int. 2008;28:238–245.
- John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010;5:1463–1470.
- Wang AY, Wang M, Lam CW, Chan IH, Lui SF, Sanderson JE. Heart failure in long-term peritoneal dialysis patients: A 4-year prospective analysis. Clin J Am Soc Nephrol. 2011;6:805–812.
- Don BR, Kaysen G. Serum albumin: Relationship to inflammation and nutrition. Semin Dial. 2004;17:432–437.
- Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis. 2005;45:891–902.
- Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2001;134:629–636.
- Fang W, Oreopoulos DG, Bargman JM. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Nephrol Dial Transplant. 2008;23:3704–3710.
- Wetmore JB, Shireman TI. The ABCs of cardioprotection in dialysis patients: A systematic review. Am J Kidney Dis. 2009;53:457–466.
- Ersoy R, Celik A, Yilmaz O, . The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats. Perit Dial Int. 2007;27:424–431.
- Heaf JG, Sarac S, Afzal S. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20:2194–2201.
- Kolesnyk I, Dekker FW, Noordzij M, le Cessie S, Struijk DG, Krediet RT. Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients. Perit Dial Int. 2007;27:446–453.